|
Balaxi Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
288.57 Cr.
|
P/BV
|
1.34
|
Book Value (Rs.)
|
39.10
|
|
52 Week High/Low (Rs.)
|
151/50
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/05/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 2.02 | 56.92 | 54.52 | 44.33 | 8.87 |
| | | | | | |
| Net CashFlow From Operating Activities | 4.87 | 6.08 | 34.14 | 0.00 | -14.06 |
| Net Cash Used In Investing Activities | -1.05 | -10.57 | -28.45 | -5.97 | -0.18 |
| Net Cash Used From Financing Activities | 30.25 | 25.51 | -0.16 | 3.65 | 18.10 |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 34.07 | 21.02 | 5.53 | -2.32 | 3.88 |
| Cash And Cash Equivalents Begin of Year | 28.21 | 7.19 | 1.66 | 3.98 | 0.10 |
| Cash And Cash Equivalents End Of Year | 62.29 | 28.21 | 7.19 | 1.66 | 3.98 |
